FluoSphera’s project is awarded a grant of CHF 1.1 million from Innosuisse
FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety under systemic conditions, today announced that...
swissbiotech.org